Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom.
Vanessa Wai Sei NgKenneth K C ManLe GaoEsther Wai Yin ChanEdwin H M LeeJoseph F HayesIan C K WongPublished in: Pharmacoepidemiology and drug safety (2021)
The prevalence of BPD diagnosis has been increasing in HK and the UK. The disparity in prescribing patterns of BPD maintenance treatment in two regions reflected three major issues in clinical practice: (1) under-prescribing of lithium in both regions, (2) antidepressant monotherapy in the UK and (3) overprescribing of valproate to women of childbearing age in HK. A review of current clinical treatment guidelines and regulations of prescribing practice by local clinicians should be immediately implemented to ensure the safe use of medications in patients with BPD.
Keyphrases